SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-063350
Filing Date
2023-11-14
Accepted
2023-11-14 07:17:11
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20231115.htm   iXBRL 8-K 47456
2 EX-99.1 itrm-ex99_1.htm EX-99.1 291164
3 GRAPHIC img185001215_0.jpg GRAPHIC 8020
  Complete submission text file 0000950170-23-063350.txt   489881

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20231115.xsd EX-101.SCH 2469
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20231115_lab.xml EX-101.LAB 14980
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20231115_pre.xml EX-101.PRE 10995
8 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20231115_htm.xml XML 5068
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 231401567
SIC: 2834 Pharmaceutical Preparations